A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female

May 10, 2018 updated by: Peking Union Medical College Hospital
This study aims to investigate the status of pelvic floor function of healthy female in China, including premenopausal nullipara, premenopausal women with childbirth and postmenopausal women.

Study Overview

Status

Unknown

Conditions

Detailed Description

This is a cross-sectional survey. The normal physical examination population is divided into three groups,including premenopausal nullipara, premenopausal women with childbirth and postmenopausal women. The pelvic floor muscle function in three groups are evaluated. The modified Oxford Grading Scale and Levator ani testing is used to quantify PFM strength through vaginal palpation. Pelvic floor muscle strength ,endurance, repetition,vaginal contraction pressure and the knack test are evaluated using a PHENIX USB 8 neuromuscular stimulation therapy system (Company: Vivaltis-Electronic Concept Lignon Innovation, Montpellier, France). In six different regions of China according to geographic region (northwest, southwest, north, east, northeast, and central-south China) , 1 or more hospitals in each area are selected as sub-centers, which needs to complete the evaluation of pelvic floor muscle function of 360 cases in 3 groups totally.

Study Type

Observational

Enrollment (Anticipated)

7920

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beiing
      • Beijing, Beiing, China, 100730
        • Recruiting
        • Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Volunteers are divided into three groups, and each clinical center requires at least 120 persons in each group.

Group A: Premenopausal women without history of abortion or delivery.

Group B: Premenopausal women with childbirth (including cesarean section or natural birth).

Group C:Postmenopausal women (except surgical menopause).

Description

Inclusion Criteria:

Group A:Premenopausal women without history of abortion or delivery

  1. Having sex life and tolerable to vaginal examination
  2. Premenopausal women without history of abortion over 16 weeks
  3. Premenopausal women without history of childbirth
  4. Planning to live locally for a long time

Group B:Premenopausal women with childbirth

  1. Having sex life and tolerable to vaginal examination
  2. Premenopausal women with childbirth (including cesarean section or natural birth).
  3. Planning to live locally for a long time

Group C:Postmenopausal women (over a year, except surgical menopause)

  1. Having sex life and tolerable to vaginal examination
  2. Postmenopausal women
  3. Planning to live locally for a long time

Exclusion Criteria:

  1. Incontinence 4 weeks before enrollment
  2. History of fecal incontinence
  3. Prolapse beyond the level of the hymen
  4. History of radical operation of pelvic cavity(cervical cancer,rectal cancer,bladder cancer, ect)
  5. History of pelvic radiotherapy
  6. History of pelvic floor surgery
  7. History of abortion over 16 weeks' pregnancy or in 1 year after delivery
  8. Duration of pregnancy
  9. Duration of lactation
  10. History of hysterectomy
  11. Latex allergy
  12. Colpitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
maximum vaginal contraction pressure
Time Frame: 1 day
it is measured by manometry, range(80-150cmH2O). The higher values represent better outcomes.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pelvic floor muscle strength
Time Frame: 1 day

The modified Oxford Grading Scale is used to quantify PFM strength through vaginal palpation. range(0-5).The higher values represent better outcomes.

through vaginal palpation.

1 day
Pelvic floor muscle strength(repetition)
Time Frame: 1 day
Levator ani testing is used to quantify PFM strength. range(0-5). The higher values represent better outcomes.
1 day
Pelvic floor muscle contraction endurance
Time Frame: 1 day
muscle contractions maintained for 0 s are defined as grade 0, 1 s as grade I, 2 s as grade II, 3 s as grade III, 4 s as grade IV, and 5 s or longer as grade V. Normal muscles can maintain the contraction for 5 s. range(0-5s). The higher values represent better outcomes.
1 day
pelvic organ prolapse quantification
Time Frame: 1 day
POP-Q is measured when maximum valsalva. range(0-4). stage 0 represents normal.
1 day
the knack test
Time Frame: 1 day
a voluntary PFM contraction before or during coughing. That the contraction could be performed represents normal.
1 day
vaginal rest pressure
Time Frame: 1 day
measure when no vaginal contraction by manometry. range(25-50 cmH2O). the lower and the higher values represent abnormal outcomes.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 10, 2018

Primary Completion (ANTICIPATED)

December 31, 2020

Study Completion (ANTICIPATED)

December 31, 2020

Study Registration Dates

First Submitted

April 13, 2018

First Submitted That Met QC Criteria

May 3, 2018

First Posted (ACTUAL)

May 4, 2018

Study Record Updates

Last Update Posted (ACTUAL)

May 11, 2018

Last Update Submitted That Met QC Criteria

May 10, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Floor

3
Subscribe